View in EDS HTML Full Text PDF Full Text

VISTA Ligation Reduces Antitumor T-Cell Activity in Pancreatic Cancer.

Saved in:
Bibliographic Details
Title: VISTA Ligation Reduces Antitumor T-Cell Activity in Pancreatic Cancer.
Authors: Digomann D; Department of Visceral, Thoracic and Vascular Surgery, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany., Strack J; Department of Visceral, Thoracic and Vascular Surgery, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany., Heiduk M; Department of Visceral, Thoracic and Vascular Surgery, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.; National Center for Tumor Diseases (NCT/UCC), 01307 Dresden, Germany.; German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328 Dresden, Germany., Plesca I; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany., Rupp L; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany., Reiche C; Department of Visceral, Thoracic and Vascular Surgery, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany., Nicolaus S; Department of Visceral, Thoracic and Vascular Surgery, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany., Beer C; Department of Visceral, Thoracic and Vascular Surgery, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany., Sommer U; Institute of Pathology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany., Schmitz M; National Center for Tumor Diseases (NCT/UCC), 01307 Dresden, Germany.; German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328 Dresden, Germany.; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Partner Site Dresden, 69120 Heidelberg, Germany., Distler M; Department of Visceral, Thoracic and Vascular Surgery, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.; National Center for Tumor Diseases (NCT/UCC), 01307 Dresden, Germany.; German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328 Dresden, Germany.; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Partner Site Dresden, 69120 Heidelberg, Germany., Weitz J; Department of Visceral, Thoracic and Vascular Surgery, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.; National Center for Tumor Diseases (NCT/UCC), 01307 Dresden, Germany.; German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328 Dresden, Germany.; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Partner Site Dresden, 69120 Heidelberg, Germany., Seifert AM; Department of Visceral, Thoracic and Vascular Surgery, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.; National Center for Tumor Diseases (NCT/UCC), 01307 Dresden, Germany.; German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328 Dresden, Germany.; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Partner Site Dresden, 69120 Heidelberg, Germany., Seifert L; Department of Visceral, Thoracic and Vascular Surgery, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.; National Center for Tumor Diseases (NCT/UCC), 01307 Dresden, Germany.; German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328 Dresden, Germany.; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Partner Site Dresden, 69120 Heidelberg, Germany.; Else Kröner Clinician Scientist Professor for 'Translational Tumor Immunological Research', 01307 Dresden, Germany.
Source: Cancers [Cancers (Basel)] 2023 Apr 17; Vol. 15 (8). Date of Electronic Publication: 2023 Apr 17.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2072-6694
DOI:10.3390/cancers15082326